AXOGEN
LIVE

Serial Number

88041171

Owner

AXOGEN CORPORATION

Attorney

John Zaccaria

First Use Date

Dec 20, 2004

Filing Date

Jul 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

AXOGEN Trademark

Serial Number: 88041171 • Registration: 6521140

AXOGEN is a trademark filed by AXOGEN CORPORATION on July 17, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AXOGEN CORPORATION (69 trademarks)

111 West Oak Avenue, 5th Floor
Tampa, FL 33602

Entity Type: 03

Trademark Details

Filing Date

July 17, 2018

Registration Date

October 12, 2021

First Use Anywhere

December 20, 2004

First Use in Commerce

July 17, 2007

Published for Opposition

June 11, 2019

Goods & Services

Providing an online forum for discussion by surgeons on a variety of topics relevant in the surgical community in the medical and veterinary fields

Scientific research for medical and veterinary purposes in the area of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; scientific research for medical and veterinary purposes in the field of plastic, orthopedic, neurology, urology, and/or ENT surgery; providing medical, veterinary and scientific research information relating to medical and veterinary treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery therefor provided through a database that allows input and collection of data and information; clinical research in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical, veterinary and biotechnology fields; development of new technology for others in the fields of pharmaceutical and veterinary preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and tissue generation, processing and transplantation

Medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; nervous tissue products for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, namely, surgical kits comprised of medical, veterinary and surgical apparatus for use in the field of surgery, namely, medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, sutures, dressing, forceps and medical and veterinary instruments for cutting tissue, surgical implants comprised of biological tissue; surgical implants comprised of synthetic materials; sensory testing instruments, namely, aesthesiometers and two-point discriminators; medical and veterinary devices, namely, devices for measuring threshold somatosensory and nerve density in humans and vertebrates; medical devices for measuring human hand's pinch strength; medical and veterinary devices, namely, a nerve function assessment monitor for use in measuring and evaluating sensory and motor function; monitoring system for medical and veterinary use comprised of components measuring pressure sensitivity on the skin, and grip and pinch strength of patients; medical and veterinary instruments and devices, namely, nerve and tissue grafts and implants comprising artificial, non-living materials, for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; implants comprising synthetic material

Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human and animal tissue, for medical and veterinary use; surgical glues; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; medical and veterinary preparations, namely, nerve and tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 13, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 13, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 13, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Oct 12, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 9, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 8, 2021 CNPR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Feb 25, 2021 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Feb 25, 2021 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Feb 25, 2021 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 13, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 2, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 2, 2021 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 2, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
ASSIGNED TO LIE
Jan 6, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 2, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 6, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 5, 2020 AITU
USE AMENDMENT FILED
May 15, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
May 15, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 28, 2020 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 19, 2019 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 19, 2019 ETOF
POST PUBLICATION AMENDMENT - ENTERED
Jun 11, 2019 CHPB
ASSIGNED TO PETITION STAFF
Jun 11, 2019 APET
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2019 NONP
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 15, 2019 EPPA
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2019 CRFA
ASSIGNED TO LIE
Apr 24, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 16, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2018 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2018 NWOS
NEW APPLICATION ENTERED
Jul 20, 2018 NWAP